NEKTAR THERAPEUTICS
Pharmaceutical Preparations · 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA 94158
공식 등기 데이터
0팔로워
1990설립
NEKTAR THERAPEUTICS 소개
Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough.
Source: Wikipedia
산업Pharmaceutical Preparations
본사455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA 94158
설립1990
상태운영 중
특허특허 1230건
POLYMER ENGINEERED FORMS OF COLONY STIMULATING FACTOR-1WO2026064439A1 · 2026
Method for enhancing cellular immunotherapyAU2020252569B2 · 2026
주요 수치
법적 정보
| 법인명 | NEKTAR THERAPEUTICS |
|---|---|
| SEC CIK | 906709SEC EDGAR에서 보기 ↗ |
| EIN | 94-3134940 |
| 업종 코드(SIC) | 2834 |
| 등기 주소 | 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA 94158 |
| 상태 | 운영 중 |
출처: SEC EDGAR · 2026년 10월 15일 업데이트
연락처 및 링크
위치
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA 94158
귀하의 회사인가요?
이 페이지를 무료로 신청하여 로고, 제품, 사진, 채용 공고를 추가하고 리뷰에 답변하세요.
이 페이지 신청